ARIAD Pharmaceuticals, Inc. was an American oncology company, now part of Takeda Oncology, which was founded in 1991 by Harvey J. Berger, M.D. and headquartered... 16 KB (1,353 words) - 18:03, 16 July 2023 |
 | along with Lightstone Ventures. In February 2017, Takeda acquired Ariad Pharmaceuticals for $5.2 billion, expanding the company's oncology and hematology... 32 KB (2,701 words) - 05:58, 27 April 2024 |
 | Brigatinib (category Drugs developed by Takeda Pharmaceutical Company) is a small-molecule targeted cancer therapy being developed by Ariad Pharmaceuticals, Inc. Brigatinib acts as both an anaplastic lymphoma kinase (ALK)... 10 KB (796 words) - 23:02, 17 April 2024 |
He was the founder and chairman and chief executive officer of ARIAD Pharmaceuticals, Inc. for 25 years, starting in 1991 and became advisor to the board... 19 KB (1,711 words) - 06:58, 28 January 2024 |
 | biotechnology companies that he founded, including Vertex Pharmaceuticals and Ariad Pharmaceuticals. He has founded or co-founded 14 biotechnology companies... 32 KB (3,390 words) - 05:34, 26 April 2024 |
Ariad Pharmaceuticals et al. v. Eli Lilly and Company, 598 F.3d 1336 (Fed. Cir. 2010) (en banc), is a United States court case regarding accusations of... 10 KB (911 words) - 01:46, 13 September 2023 |
 | Ponatinib (category Drugs developed by Takeda Pharmaceutical Company) chromosome–positive (Ph+) acute lymphoblastic leukemia. It was developed by Ariad Pharmaceuticals. It is a multi-targeted tyrosine-kinase inhibitor. Some forms of... 20 KB (1,623 words) - 05:55, 10 April 2024 |
 | Ridaforolimus (category Drugs developed by Takeda Pharmaceutical Company) Ridaforolimus is being co-developed by Merck and ARIAD Pharmaceuticals. On May 5, 2010, Ariad Pharmaceuticals and Merck & Company announced a clinical development... 8 KB (680 words) - 22:27, 10 February 2024 |
 | of resistance to other chemotherapeutic agents. Independently, ARIAD pharmaceuticals, adapting the chemical structures from first and second-generation... 33 KB (3,797 words) - 16:45, 29 April 2024 |
in cancer and brain development. He is a founder of Ariad Pharmaceuticals, Amplyx Pharmaceuticals, and Foghorn Therapeutics. Crabtree grew up near Wellsburg... 23 KB (2,699 words) - 19:11, 23 April 2024 |